17.74
price up icon3.26%   0.56
 
loading
Schlusskurs vom Vortag:
$17.18
Offen:
$17.31
24-Stunden-Volumen:
423.98K
Relative Volume:
0.63
Marktkapitalisierung:
$2.24B
Einnahmen:
$628.25M
Nettoeinkommen (Verlust:
$-78.55M
KGV:
-23.04
EPS:
-0.77
Netto-Cashflow:
$-29.73M
1W Leistung:
+15.49%
1M Leistung:
+35.73%
6M Leistung:
+24.58%
1J Leistung:
-6.78%
1-Tages-Spanne:
Value
$17.31
$17.78
1-Wochen-Bereich:
Value
$14.99
$17.78
52-Wochen-Spanne:
Value
$12.77
$21.22

Neogenomics Inc Stock (NEO) Company Profile

Name
Firmenname
Neogenomics Inc
Name
Telefon
(239) 768-0600
Name
Adresse
9490 NEOGENOMICS WAY, FORT MYERS, FL
Name
Mitarbeiter
2,100
Name
Twitter
@NeoGenomics
Name
Nächster Verdiensttermin
2024-11-05
Name
Neueste SEC-Einreichungen
Name
NEO's Discussions on Twitter

Vergleichen Sie NEO mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Diagnostics & Research icon
NEO
Neogenomics Inc
17.74 2.24B 628.25M -78.55M -29.73M -0.77
Diagnostics & Research icon
TMO
Thermo Fisher Scientific Inc
521.66 199.82B 42.37B 6.14B 7.78B 15.26
Diagnostics & Research icon
DHR
Danaher Corp
238.83 173.66B 23.74B 3.89B 4.98B 7.93
Diagnostics & Research icon
A
Agilent Technologies Inc
138.14 38.64B 6.51B 1.29B 1.37B 3.82
Diagnostics & Research icon
IQV
Iqvia Holdings Inc
201.43 36.52B 15.32B 1.41B 1.96B 5.95
Diagnostics & Research icon
IDXX
Idexx Laboratories Inc
421.76 34.55B 3.84B 866.24M 792.60M 9.80

Neogenomics Inc Stock (NEO) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2024-05-01 Fortgesetzt Craig Hallum Buy
2023-12-29 Bestätigt BTIG Research Buy
2023-08-21 Hochstufung Stephens Equal-Weight → Overweight
2023-05-16 Herabstufung Raymond James Outperform → Mkt Perform
2023-05-09 Hochstufung BTIG Research Neutral → Buy
2023-02-24 Hochstufung The Benchmark Company Hold → Buy
2023-02-01 Hochstufung Needham Hold → Buy
2022-08-26 Herabstufung The Benchmark Company Buy → Hold
2022-08-22 Herabstufung Needham Buy → Hold
2022-06-03 Eingeleitet Piper Sandler Overweight
2022-03-29 Herabstufung BofA Securities Buy → Neutral
2022-03-29 Herabstufung Stephens Overweight → Equal-Weight
2022-01-18 Fortgesetzt Stephens Overweight
2021-12-16 Eingeleitet Cowen Outperform
2021-11-05 Herabstufung Morgan Stanley Overweight → Equal-Weight
2021-10-14 Hochstufung Raymond James Mkt Perform → Outperform
2021-06-03 Eingeleitet Goldman Buy
2021-02-25 Fortgesetzt Needham Buy
2021-02-25 Herabstufung Raymond James Outperform → Mkt Perform
2021-01-28 Eingeleitet Truist Buy
2020-12-11 Fortgesetzt BTIG Research Buy
2020-10-28 Bestätigt Needham Buy
2020-09-09 Eingeleitet Morgan Stanley Overweight
2020-08-28 Eingeleitet Guggenheim Buy
2020-07-29 Bestätigt Needham Buy
2020-06-25 Eingeleitet BofA/Merrill Buy
2020-04-21 Fortgesetzt Stephens Overweight
2020-03-02 Fortgesetzt Craig Hallum Buy
2020-02-28 Hochstufung First Analysis Sec Outperform → Strong Buy
2020-01-23 Herabstufung First Analysis Sec Strong Buy → Outperform
2019-10-30 Bestätigt Needham Buy
2019-05-01 Bestätigt Needham Buy
2019-03-29 Bestätigt Needham Buy
2019-01-03 Eingeleitet Needham Buy
2018-10-24 Hochstufung First Analysis Sec Outperform → Strong Buy
2018-08-21 Eingeleitet Leerink Partners Outperform
2018-05-02 Herabstufung First Analysis Sec Overweight → Equal-Weight
2017-09-11 Herabstufung BTIG Research Buy → Neutral
2017-08-24 Eingeleitet Gabelli & Co Buy
2016-12-15 Eingeleitet Cantor Fitzgerald Overweight
Alle ansehen

Neogenomics Inc Aktie (NEO) Neueste Nachrichten

pulisher
Nov 27, 2024

Loomis Sayles & Co. L P Invests $17.81 Million in NeoGenomics, Inc. (NASDAQ:NEO) - MarketBeat

Nov 27, 2024
pulisher
Nov 23, 2024

NeoGenomics, Inc. (NASDAQ:NEO) Stocks Shoot Up 25% But Its P/S Still Looks Reasonable - Simply Wall St

Nov 23, 2024
pulisher
Nov 23, 2024

NeoGenomics, Inc. (NASDAQ:NEO) Stock Holdings Raised by Jennison Associates LLC - MarketBeat

Nov 23, 2024
pulisher
Nov 22, 2024

NeoGenomics Inc (NEO) Shares Up 4.09% on Nov 22 - GuruFocus.com

Nov 22, 2024
pulisher
Nov 22, 2024

Gene Panel Market to Surpass USD 11.75 Billion by 2031 | SkyQuest Technology - GlobeNewswire Inc.

Nov 22, 2024
pulisher
Nov 21, 2024

NeoGenomics to present new data at AMP 2024 - SelectScience

Nov 21, 2024
pulisher
Nov 20, 2024

NeoGenomics, Inc. (NASDAQ:NEO) Q3 2024 Earnings Call Transcript - MSN

Nov 20, 2024
pulisher
Nov 20, 2024

NeoGenomics, Inc. (NASDAQ:NEO) Shares Purchased by Segall Bryant & Hamill LLC - MarketBeat

Nov 20, 2024
pulisher
Nov 20, 2024

NeoGenomics general counsel sells $79,475 in stock - Investing.com India

Nov 20, 2024
pulisher
Nov 19, 2024

NeoGenomics general counsel sells $79,475 in stock By Investing.com - Investing.com UK

Nov 19, 2024
pulisher
Nov 19, 2024

NeoGenomics to Present New Data at AMP 2024, Highlighting the Impact of ctDNA and NGS for Advancing Cancer Diagnostics and Personalized Treatment - Milton Daily Standard

Nov 19, 2024
pulisher
Nov 15, 2024

Los Angeles Capital Management LLC Invests $1.10 Million in NeoGenomics, Inc. (NASDAQ:NEO) - MarketBeat

Nov 15, 2024
pulisher
Nov 14, 2024

T. Rowe Price Investment Management Reduces Stake in NeoGenomics Inc - GuruFocus.com

Nov 14, 2024
pulisher
Nov 14, 2024

Janus Henderson Group PLC's Strategic Reduction in NeoGenomics I - GuruFocus.com

Nov 14, 2024
pulisher
Nov 14, 2024

Felicia Williams Joins NeoGenomics Board of Directors - The Bakersfield Californian

Nov 14, 2024
pulisher
Nov 14, 2024

Trend Tracker for (NEO) - Stock Traders Daily

Nov 14, 2024
pulisher
Nov 12, 2024

Pathological Examination Market to Grow with Leading Key - openPR

Nov 12, 2024
pulisher
Nov 09, 2024

Creative Planning Purchases 7,004 Shares of NeoGenomics, Inc. (NASDAQ:NEO) - Defense World

Nov 09, 2024
pulisher
Nov 08, 2024

NeoGenomics to Participate in the Piper Sandler 36th Annual Healthcare Conference - BioSpace

Nov 08, 2024
pulisher
Nov 08, 2024

NeoGenomics, Inc. (NASDAQ:NEO) Receives $19.89 Consensus Target Price from Brokerages - Defense World

Nov 08, 2024
pulisher
Nov 08, 2024

NeoGenomics (NEO) Upgraded to Strong Buy: Here's What You Should Know - MSN

Nov 08, 2024
pulisher
Nov 07, 2024

NeoGenomics posts $18M net loss in Q3 - Gulfshore Business

Nov 07, 2024
pulisher
Nov 07, 2024

Earnings call: NeoGenomics sees growth with NGS and new test launches - Investing.com Canada

Nov 07, 2024
pulisher
Nov 06, 2024

NeoGenomics' (NEO) Buy Rating Reiterated at Needham & Company LLC - MarketBeat

Nov 06, 2024
pulisher
Nov 06, 2024

NeoGenomics Third Quarter 2024 Earnings: EPS Beats Expectations - Yahoo Finance

Nov 06, 2024
pulisher
Nov 05, 2024

NeoGenomics Reports Strong Q3 2024 Growth - TipRanks

Nov 05, 2024
pulisher
Nov 05, 2024

NeoGenomics (NEO) Reports Q3 Earnings: What Key Metrics Have to Say - MSN

Nov 05, 2024
pulisher
Nov 05, 2024

NeoGenomics receives New York state approval for its solid tumor test - MSN

Nov 05, 2024
pulisher
Nov 05, 2024

NeoGenomics: Q3 Earnings Snapshot - The Washington Post

Nov 05, 2024
pulisher
Nov 05, 2024

NeoGenomics (NASDAQ:NEO) Updates FY 2024 Earnings Guidance - MarketBeat

Nov 05, 2024
pulisher
Nov 05, 2024

NeoGenomics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nov 05, 2024
pulisher
Nov 05, 2024

NeoGenomics Reports Third Quarter 2024 Results - Business Wire

Nov 05, 2024
pulisher
Nov 05, 2024

NeoGenomics, Inc. (NASDAQ:NEO) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat

Nov 05, 2024
pulisher
Nov 04, 2024

Wall Street Analysts Believe NeoGenomics (NEO) Could Rally 51.29%: Here's is How to Trade - MSN

Nov 04, 2024
pulisher
Nov 03, 2024

Emerald Mutual Fund Advisers Trust Sells 314,330 Shares of NeoGenomics, Inc. (NASDAQ:NEO) - MarketBeat

Nov 03, 2024
pulisher
Nov 03, 2024

Allspring Global Investments Holdings LLC Reduces Stake in NeoGenomics, Inc. (NASDAQ:NEO) - Defense World

Nov 03, 2024
pulisher
Nov 03, 2024

NeoGenomics (NEO) Set to Announce Quarterly Earnings on Tuesday - Defense World

Nov 03, 2024
pulisher
Nov 02, 2024

Blue Trust Inc. Boosts Stake in NeoGenomics, Inc. (NASDAQ:NEO) - Defense World

Nov 02, 2024
pulisher
Oct 23, 2024

NeoGenomics gains conditional approval for solid tumour assays in New York - Medical Device Network

Oct 23, 2024
pulisher
Oct 22, 2024

NeoGenomics NGS tests gain New York State approval - Investing.com

Oct 22, 2024
pulisher
Oct 22, 2024

NEONeoGenomics, Inc. Latest Stock News & Market Updates - StockTitan

Oct 22, 2024
pulisher
Oct 22, 2024

NeoGenomics Receives New York State Approval for Neo Comprehensive™ Solid Tumor Test - Business Wire

Oct 22, 2024
pulisher
Oct 22, 2024

Clinical Laboratory Tests Market 2023-2031 | Latest Overview Analysis Report - InsightAce Analytic

Oct 22, 2024
pulisher
Oct 17, 2024

Truist Financial Corp Sells 4,699 Shares of NeoGenomics, Inc. (NASDAQ:NEO) - Defense World

Oct 17, 2024
pulisher
Oct 16, 2024

NeoGenomics (NASDAQ:NEO) Shares Down 2.5%Should You Sell? - MarketBeat

Oct 16, 2024

Finanzdaten der Neogenomics Inc-Aktie (NEO)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
diagnostics_research LH
$242.15
price up icon 1.43%
$168.45
price up icon 0.08%
$144.36
price up icon 0.99%
diagnostics_research WAT
$386.57
price down icon 0.41%
diagnostics_research MTD
$1,243.40
price up icon 0.90%
$421.76
price up icon 1.06%
Kapitalisierung:     |  Volumen (24h):